The screening role of a biomarker panel in BALF among patients with cancer-suspected pulmonary nodules less than 8 mm.

Wei XiongWei DingMei XuBigyan PudasainiJinyuan SunYunfeng Zhao

Published in: The clinical respiratory journal (2020)

For patients with cancer-suspected pulmonary nodules less 8 mm, a biomarker panel of VEGF, TGF-β and HGF in BALF demonstrated more eligible screening efficiency for the preliminary differentiation of malignancy from benignancy, by contrast with their level in blood as well as PET/CT.

Keyphrases

pet ct
pulmonary hypertension
pulmonary embolism
positron emission tomography
magnetic resonance
vascular endothelial growth factor
endothelial cells
transforming growth factor
computed tomography
epithelial mesenchymal transition